Nutrient Sensing and Transcriptional Regulation
Nutrient Sensing and Transcriptional Regulation
批准号:
10174861
负责人:
Donald E Ayer
金额:
$39.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-06-30
关键词:
AffectAgeBiologyBiotinBranched-Chain Amino AcidsBreast Cancer CellBreast Cancer cell lineCancer BiologyCatabolismCell Culture TechniquesCellsChIP-seqChoices and ControlClinicalCritical PathwaysDependenceDiseaseEquilibriumGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGenomic approachGlucoseGlycolysisGoalsGrowthHypoxiaIn VitroKetonesLabelMaintenanceMalignant NeoplasmsMetabolicMetabolismMitochondriaMolecularNormal CellNutrientOncogenesOutcomeOxidative PhosphorylationOxygenPathologicPathway interactionsPlayProteinsRoleShapesSignal TransductionSurvival RateTXNIP geneTestingTherapeuticTherapeutic InterventionTranscriptional RegulationWarburg EffectXenograft procedureaerobic glycolysisaggressive breast cancerc-myc Genescancer cellcancer subtypescofactordetection of nutrientexperimental studyextracellularglucose uptakein vitro activityin vivointerestmalignant breast neoplasmmemberneoplastic cellnew therapeutic targetnoveloxidationpatient derived xenograft modelprogramsresponsesensortargeted treatmenttherapeutic developmenttissue culturetranscription factortranscriptometranscriptome sequencingtriple-negative invasive breast carcinomatumortumor growthtumor microenvironmenttumor xenografttumorigenesis
中文摘要
乳腺癌是一种异质性疾病,由几种临床和分子上不同的
亚型与其他亚型相比,三阴性乳腺癌(TNBC)占所有乳腺癌的15-20%。
乳腺癌发生在较年轻的年龄,复发更频繁,生存率降低。当前没有任何
靶向疗法可用于TNBC。我们的短期目标是剖析
支持TNBC的增长和生存。我们的长期目标是利用这些发现来确定新的目标
适合治疗发展。我们专注于正常细胞和癌细胞如何整合内部和
细胞外生长和营养信号以维持生长和肿瘤发生。我们最感兴趣的是
转录因子的扩展Myc网络的两个成员整合生长和营养信号。c-Myc
和MondoA的功能相反,以控制TNBC的侵袭性生长和存活。本申请中
我们专注于MondoA对基因表达的控制,以及代谢如何塑造MondoA依赖的基因表达。
体外和体内转录组。MondoA是葡萄糖依赖性转录的主要调节因子,
硫氧还蛋白相互作用蛋白(TXNIP)是其最具特征的直接和葡萄糖诱导的转录因子,
目标TXNIP具有多效性。在这些功能中,最具特点的是燃料选择。
TXNIP是葡萄糖摄取和有氧糖酵解的有效抑制剂,但它也可以驱动
其他燃料如支链氨基酸和线粒体中的酮。因此,高TXNIP水平驱动
线粒体中的燃料氧化,同时限制葡萄糖的利用。相反,低TXNIP水平提示燃料使用
而不是线粒体。我们已经证明了几种主要的癌基因阻断了
MondoA转录活性,从而降低TXNIP水平。这可能有助于癌基因-
依赖性有氧糖酵解,即瓦尔堡效应,这是癌细胞的共同特征。我们提出
研究燃料的选择如何控制MondoA在体外和体内的转录活性,以及来自细胞的信号如何影响MondoA的转录活性。
肿瘤微环境决定MondoA转录活性。在目标1中,我们将确定TXNIP,
缺氧以及糖酵解和氧化磷酸化之间的平衡如何控制MondoA
转录活性在目标2中,我们将确定是否需要MondoA来建立或
肿瘤发生的维持以及MondoA在良好灌注/氧合的细胞中是否具有转录活性
肿瘤区域。为了检验我们发现的普遍性,我们将确定MondoA在基因表达中的作用。
以及利用其他乳腺癌细胞系和条件性重编程乳腺癌细胞进行营养感测
PDX模型在目标3中,我们将使用基因组学方法来发现直接依赖于MondoA的
体内转录组,并确定这些基因如何与MondoA协作以维持TNBC
肿瘤发生我们还将发现MondoA体内转录活性所需的辅因子,
生物素邻近标记。
英文摘要
SUMMARY Breast cancer is a heterogeneous disease consisting of several clinically and molecularly distinct
subtypes. Compared to other subtypes, Triple Negative Breast Cancer (TNBC), which represents 15-20% of all
breast cancer, occurs at a younger age and recurs more frequently with a reduced survival rate. Currently, no
targeted therapies are available for TNBC. Our short-term goal is to dissect the molecular pathways that
support TNBC growth and survival. Our long-term goal is to leverage these discoveries to identify novel targets
suitable for therapeutic development. We focus on how normal cells and cancer cells integrate intra- and
extracellular growth and nutrient signals to sustain growth and tumorigenesis. We are most interested in how
two members of the extended Myc network of transcription factors integrate growth and nutrient signals. c-Myc
and MondoA function in opposition to control the aggressive growth and survival of TNBC. In this application
we focus on the control of gene expression by MondoA and how metabolism shapes the MondoA-dependent
transcriptome in vitro and in vivo. MondoA is the principal regulator of glucose-dependent transcription with
Thioredoxin Interacting Protein (TXNIP) being its best-characterized direct and glucose-induced transcriptional
target. TXNIP has pleiotropic function. Best characterized among these many functions is one in fuel choice.
TXNIP is a potent suppressor of glucose uptake and aerobic glycolysis, but it can also drive the catabolism of
other fuels such as branched chain amino acids and ketones in mitochondria. Thus, high TXNIP levels drive
fuel oxidation in mitochondria, while restricting utilization of glucose. Conversely, low TXNIP levels tip fuel use
towards glucose and away from mitochondria. We have shown that several predominant oncogenes block
MondoA transcriptional activity, thereby decreasing TXNIP levels. This likely contributes to oncogene-
dependent aerobic glycolysis, i.e. the Warburg Effect, which is a common feature of cancer cells. We propose
to study how fuel choice controls MondoA transcriptional activity in vitro and in vivo and how signals from the
tumor microenvironment dictate MondoA transcriptional activity. In Aim 1, we will determine how TXNIP,
hypoxia and how the balance between glycolysis and oxidative phosphorylation controls MondoA
transcriptional activity. In Aim 2, we will determine whether MondoA is required for the establishment or
maintenance of tumorigenesis and whether MondoA is transcriptionally active in well perfused/oxygenated
tumor regions. To examine the generality of our findings, we will determine MondoA’s role in gene expression
and nutrient-sensing using other breast cancer cell lines and in conditionally reprogrammed breast cancer cells
from PDX models. In Aim 3, we will use genomics approaches to discover the direct MondoA-dependent
transcriptome in vivo and determine how these genes collaborate with MondoA to sustain TNBC
tumorigenesis. We will also discover the cofactors required for MondoA transcriptional activity in vivo using
biotin proximity labeling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Huntsman Cancer Institute (HCI) Cancer Genetics, Epigenetics, Models, and Signaling (Cancer GEMS) Training Program
-
批准号:10627604
-
项目类别:
-
资助金额:$19.69万
-
财政年份:2023
-
负责人:Donald E Ayer
-
依托单位:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
-
批准号:10474257
-
项目类别:
-
资助金额:$54.0万
-
财政年份:2019
-
负责人:Donald E Ayer
-
依托单位:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
-
批准号:9792209
-
项目类别:
-
资助金额:$42.03万
-
财政年份:2019
-
负责人:Donald E Ayer
-
依托单位:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
-
批准号:10661674
-
项目类别:
-
资助金额:$53.93万
-
财政年份:2019
-
负责人:Donald E Ayer
-
依托单位:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
-
批准号:10005296
-
项目类别:
-
资助金额:$54.0万
-
财政年份:2019
-
负责人:Donald E Ayer
-
依托单位:
Nutrient Sensing and Transcriptional Regulation
-
批准号:10421294
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2018
-
负责人:Donald E Ayer
-
依托单位:
Transcriptional control of skeletal muscle insulin resistance
-
批准号:8299142
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2010
-
负责人:Donald E Ayer
-
依托单位:
Transcriptional control of skeletal muscle insulin resistance
-
批准号:8463513
-
项目类别:
-
资助金额:$28.81万
-
财政年份:2010
-
负责人:Donald E Ayer
-
依托单位:
Transcriptional control of skeletal muscle insulin resistance
-
批准号:7918568
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2010
-
负责人:Donald E Ayer
-
依托单位:
Transcriptional control of skeletal muscle insulin resistance
-
批准号:8076333
-
项目类别:
-
资助金额:$29.97万
-
财政年份:2010
-
负责人:Donald E Ayer
-
依托单位:
Modulators of Mad Family Function: MIx and mSin3A
-
批准号:7911391
-
项目类别:
-
资助金额:$26.44万
-
财政年份:2009
-
负责人:Donald E Ayer
-
依托单位:
Multidisciplinary Cancer Research Training Program
-
批准号:7928333
-
项目类别:
-
资助金额:$13.42万
-
财政年份:2009
-
负责人:Donald E Ayer
-
依托单位:
Transcriptional control in the genesis of pancreatic intraepithelial neoplasia
-
批准号:7241866
-
项目类别:
-
资助金额:$14.95万
-
财政年份:2007
-
负责人:Donald E Ayer
-
依托单位:
Transcriptional control in the genesis of pancreatic intraepithelial neoplasia
-
批准号:7382586
-
项目类别:
-
资助金额:$17.94万
-
财政年份:2007
-
负责人:Donald E Ayer
-
依托单位:
Multidisciplinary Cancer Research Training Program
-
批准号:7477937
-
项目类别:
-
资助金额:$48.43万
-
财政年份:2002
-
负责人:Donald E Ayer
-
依托单位:
Multidisciplinary Cancer Research Training Program
-
批准号:7168369
-
项目类别:
-
资助金额:$49.36万
-
财政年份:2002
-
负责人:Donald E Ayer
-
依托单位:
Casein Kinase I and the Regulation of Circadian Rhythm
-
批准号:7590358
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2002
-
负责人:Donald E Ayer
-
依托单位:
Multidisciplinary Cancer Research Training Program
-
批准号:7665027
-
项目类别:
-
资助金额:$53.37万
-
财政年份:2002
-
负责人:Donald E Ayer
-
依托单位:
Multidisciplinary Cancer Research Training Program
-
批准号:8116068
-
项目类别:
-
资助金额:$51.11万
-
财政年份:2002
-
负责人:Donald E Ayer
-
依托单位:
Multidisciplinary Cancer Research Training Program
-
批准号:7900548
-
项目类别:
-
资助金额:$55.01万
-
财政年份:2002
-
负责人:Donald E Ayer
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: